Arai Katsuhito, Mizobuchi Yu, Tokuji Yoshihiko, Aida Kazuhiko, Yamashita Shinji, Ohnishi Masao, Kinoshita Mikio
Department of Food Science, Obihiro University of Agriculture and Veterinary Medicine.
J Oleo Sci. 2015;64(7):737-42. doi: 10.5650/jos.ess15005.
The effects of dietary plant-origin glucosylceramide (GlcCer) on symptoms similar to those of inflammatory bowel diseasewere investigated in dextran sulfate sodium salt (DSS)-treated mice. Dietary GlcCer suppressed decreases in body weight due to DSS administration. To determine its effects on the colon, we examined its surface under a microscope following toluidine blue staining. Dietary GlcCer decreased DSS-induced chorionic crypt injury and elevated myeloperoxidase levels. Moreover, dietary GlcCer significantly suppressed the production of cytokines by the intestinal mucosa. These results provide evidence for the suppression of DSS-induced inflammation by dietary GlcCer.
在葡聚糖硫酸钠(DSS)处理的小鼠中,研究了膳食中植物来源的葡萄糖神经酰胺(GlcCer)对类似于炎症性肠病症状的影响。膳食中的GlcCer抑制了因给予DSS而导致的体重下降。为了确定其对结肠的影响,我们在甲苯胺蓝染色后在显微镜下检查了结肠表面。膳食中的GlcCer减少了DSS诱导的绒毛隐窝损伤,并提高了髓过氧化物酶水平。此外,膳食中的GlcCer显著抑制了肠黏膜细胞因子的产生。这些结果为膳食中的GlcCer抑制DSS诱导的炎症提供了证据。